Ordinary Share Capital Changement Date
AbbVie USD 18M 0 2024-12
Agios Pharmaceuticals USD 58.04M 57.96M 2025-06
ALKERMES USD 165.05M 163.25M 2025-06
Amgen USD 33.58B 45M 2025-03
Biogen USD 146.6M 146.5M 2025-06
BioMarin Pharmaceutical USD 192K 1000 2025-03
Bristol-Myers Squibb USD 2.04B 1.74B 2025-06
Eli Lilly USD 592.6M 200K 2025-03
Exelixis USD 270.13M 269.86M 2025-07
Genmab DKK 10M 56M 2025-03
Gilead Sciences USD 1000K 0 2024-12
GlaxoSmithKline GBP 4.15B 2.8B 2025-06
Glaxosmithkline GBP 1.35B 0 2024-12
Incyte USD 194.12M 193.93M 2025-06
Ionis Pharmaceuticals USD 159.2M 159.04M 2025-06
J&J USD 3.12B 0 2025-03
Merck USD 1.79B 0 2025-03
Moderna USD 38.7K 100 2025-03
Neurocrine Biosciences USD 99M 98.9M 2025-03
Novartis USD 793M 0 2024-12
Novartis USD 793M 0 2024-12
Pfizer USD 481M 1000K 2025-03
PTC Therapeutics USD 78K 1000 2025-03
Regeneron Pharmaceuticals USD 0 102K 2025-03
Roche Holding CHF 107M 0 2024-06
Sanofi 1.25B 52.53M 2025-03
Sarepta Therapeutics USD 10K 0 2025-03
Takeda JPY 1.56B 1.69T 2025-06
Teva Pharmaceutical Industries USD 58M 0 2024-09
Ultragenyx Pharmaceutical USD 92K 0 2024-12
Vertex Pharmaceuticals USD 2.6M 0 2024-12


Amgen Capital Ordinaire - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.